Please login to the form below

Not currently logged in
Email:
Password:

Proximagen

This page shows the latest Proximagen news and features for those working in and with pharma, biotech and healthcare.

BenevolentAI raises $115m to fund drug development

BenevolentAI raises $115m to fund drug development

BenevolentAI currently has 22 validated drug candidate programmes on the go, according to chief executive Ken Mulvany, formerly CEO of Proximagen, who describes the company as “a fully integrated, AI enabled

Latest news

  • Artificial intelligence firm licenses Janssen candidates for development Artificial intelligence firm licenses Janssen candidates for development

    BenevolentAI was founded in 2013 as a spin-out of pharmaceutical company Proximagen.

  • Roche drops superbug partnership with Polyphor Roche drops superbug partnership with Polyphor

    Roche drops superbug partnership with Polyphor. But adds inflammation research agreement with Proximagen. ... VAP-1 is a cell-adhesion molecule that may have a role to play in the treatment of inflammation, and Proximagen has taken its inhibitor into a

  • Pharma deals for June 2012 Pharma deals for June 2012

    Upsher-Smith took the acquisition route to replenish its pipeline, in this case by acquiring its long-term partner Proximagen. ... Proximagen's phase II compound PRX00933 has the same mechanism-of-action. Proximagen will receive an upfront payment of

  • High hopes

    Proximagen eyes AIM. Another university spin-out, Proximagen, is also planning to list on the stock market.

  • The waiting game

    Encouraging maiden interim results from Proximagen Neuroscience, a drug company specialising in neurodegenerative diseases, gave its depressed share price a useful lift.

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    its other companies Proximagen, an early-stage drug discovery and development company, and Pairnomix, a genetics research company.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
McCann Complete Medical

Complete Medical delivers world-class solutions in medical communications, regulatory services, healthcare multichannel excellence, and strategic consultancy. We bring together specialist...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics